Search Results - "CASANOVAS, T."

Treatment Discontinuation after HBsAg Loss is Safe in Chronic Hepatitis B Patients Treated with Nucleos/Tide Analogs: A Retrospective Multicenter Study (HEBESAS) by Suárez, E, Simón, M.A, Buti, M, Prieto, M, Pascasio, J.M, Rodríguez, M, Casanovas, T, Crespo, J, Arenas, J, Gómez, R, Figueruela, B, Diago, M, Morillas, R.M, Zozaya, J.M, Calleja, J.L, Casado, M, Molina, E, Fuentes, J

Get full text

Identifying Improved and Non-improved Aspects of Health-related Quality of Life After Liver Transplantation Based on the Assessment of the Specific Questionnaire Liver Disease Quality of Life by Casanovas, T, Herdman, M, Chandía, A, Peña, M.C, Fabregat, J, Vilallonga, J.-S

“…Abstract Introduction The specific questionnaire Liver Disease Quality of Life ( LDQOL) is a valid tool for measuring quality of life (QOL) and has been used…”
Get full text

P0649 : Characterization of HBsAg loss in patients with chronic hepatitis B (CHB) treated with nucleos/tide analogs (NUCs): A retrospective multicenter study (HEBESAS) by Suárez, E, Simón, M.A, Buti, M, Prieto, M, Pascasio, J.M, Rodríguez, M, Casanovas, T, Crespo, J, Arenas, J, Gómez, R, Figueruela, B, Diago, M, Morillas, R, Zozaya, J.M, Calleja, J.L, Casado, M, Molina, E, Fuentes, J

Get full text

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C by Féray, Cyrille, Caccamo, Lucio, Alexander, Graeme J.M., Ducot, Béatrice, Gugenheim, Jean, Casanovas, Teresa, Loinaz, Carmelo, Gigou, Michele, Burra, Patrizia, Barkholt, Lisbeth, Esteban, Raffael, Bizollon, Thierry, Lerut, Jan, Minello–Franza, Anne, Bernard, Pierre–Henri, Nachbaur, Karl, Botta–Fridlund, Danielle, Bismuth, Henri, Schalm, Solko W., Samuel, Didier

“…Background & Aims: Liver transplantation for hepatitis C virus (HCV)-related liver disease is characterized by frequent graft infection by HCV. The prognosis…”
Get full text

Everolimus in Clinical Practice in Long-Term Liver Transplantation: An Observational Study by Casanovas, T, Argudo, A, Peña-Cala, M.C

“…Abstract Introduction Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, has been used in acute and chronic treatment of kidney and heart…”
Get full text

Effectiveness and Safety of Everolimus in the Treatment of Autoimmune Hepatitis Related to Anti-Hepatitis C Virus Therapy After Liver Transplant: Three Case Reports by Casanovas, T, Argudo, A, Peña-Cala, M.C

“…Abstract Treatment of recurrent hepatitis C after liver transplantation is indicated in selected cases. During the combined treatment with pegylated interferon…”
Get full text

Gastrointestinal Complications in Liver Transplant Recipients: MITOS Study by Herrero, J.I, Benlloch, S, Bernardos, A, Bilbao, I, Castells, L, Castroagudin, J.F, González, L, Irastorza, I, Navasa, M, Otero, A, Pons, J.A, Rimola, A, Suárez, F, Casanovas, T, Otero, E, Rodríguez, M, Serrano, T, Otero, S, López, I, Miras, M, Prieto, M

“…Abstract Introduction Liver transplant recipients frequently suffer gastrointestinal (GI) complications but their prevalence and their influence on quality of…”
Get full text

Health-Related Quality of Life Before and After a Solid Organ Transplantation (Kidney, Liver, and Lung) of Four Catalonia Hospitals by Ortega, T, Deulofeu, R, Salamero, P, Roman, A, Masnou, N, Rubio, S, Garcia, O, Casanovas, T, Cofán, F, Twose, J, Ortega, F

“…Abstract Introduction and Aims It has been described that patients who receive a transplant display a better Health Related Quality of Life (HRQoL). Our…”
Get full text

24 HIGHER SUSTAINED VIROLOGIC RESPONSE AND HISTOLOGIC IMPROVEMENT IN RECURRENT HEPATITIS C AFTER PEGYLATED INTERFERON PLUS RIBAVIRIN THERAPY UNDER CYCLOSPORINE-BASED VERSUS TACROLIMUS-BASED IMMUNOSUPPRESSIVE THERAPY by Navasa, M, Casanovas, T, Berenguer, M, Fernández, I, Salcedo, M, Castells, L, Pascasio, J, Fernández, J, Herrero, I, Otero, A, Tomé, S, de la Mata, M, Bárcena, R, Baños, I, Guilera, M

Get full text

Impact of Health Related Quality of Life in Catalonia Liver Transplant Patients by Ortega, T, Deulofeu, R, Salamero, P, Casanovas, T, Rimola, A, Pont, T, Caldes, A, Twose, J, Ortega, F

“…Abstract Objective Our aim was to study the changes in the Health Related Quality of Life (HRQoL) during the first year following liver transplantation…”
Get full text

Perceived State of Health is Worse in Kidney Recipients Younger Than 60 Years vs Older Than 60 Years by Ortega, T, Deulofeu, R, Salamero, P, Lauzurica, R, Casanovas, T, Cofán, F, Nobel, L, Jane, L, Twose, J, Ortega, F

“…Abstract Objective To evaluate the differences in perceived state of health (PSH) according to patient age younger or older than 60 years. Patients and Methods…”
Get full text

Validation of the Spanish Version of the Liver Disease Quality of Life Instrument Among Candidates for Liver Transplant by Casanovas Taltavull, T, Jané Cabré, L, Herdman, M, Casado Collado, A, Pubill, B. Prat, Fabregat Prous, J

“…Abstract Objective To validate a Spanish version of the Liver Disease Quality of Life Questionnaire (LDQOL 1.0) among patients awaiting hepatic…”
Get full text

Study on the Efficacy and Safety of Adefovir Dipivoxil Treatment in Post–Liver Transplant Patients With Hepatitis B Virus Infection and Lamivudine-Resistant Hepatitis B Virus by Bárcena, R., Del Campo, S., Moraleda, G., Casanovas, T., Prieto, M., Buti, M., Moreno, J.M., Cuervas, V., Fraga, E., De la Mata, M., Otero, A., Delgado, M., Loinaz, C., Barrios, C., Dieguez, M.L.G., Mas, A., Sousa, J.M., Herrero, J.I., Muñoz, R., Avilés, J.F., Gonzalez, A., Rueda, M.

“…Hepatitis B virus (HBV) recurrence and de novo HBV infection are frequent events in liver transplantation recipients. Treatment with lamivudine is initially…”
Get full text

Treatment of HCV with Simeprevir Associated to Daclatasvir in Patients with Stage 4 and 5 Chronic Renal Failure by Baliellas, C, Marquez-Rodriguez, P, Castellote, J, Casanovas-Taltavull, T, Rota, R, Girbau, A, Dueñas, E, Cachero, A, Xiol, X

Get full text

Clinical and Virological Effects During Two Years of Ongoing Adefovir Dipivoxil in the Treatment of Lamivudine-Resistant Chronic Hepatitis B Infection by Gornals, J.B., Casanovas, T., Sabidó, M., Baliellas, C., Casanovas, A., Cañas, C., Serrano, T., Verdura, B., Chahri, N., Gil-Vernet, S., Figueras, J.

“…Our aim was to evaluate the efficacy and safety of adding adefovir to lamivudine therapy for hepatitis B virus (HBV)-infected patients resistant to Ramivudine…”
Get full text

Validation of the Spanish version of the Liver Disease Quality of Life questionnaire in transplant patients by Casanovas, T, Vallejo, G, Herdman, M, Casado, A, Ribas, S, Rodríguez Fariña, E, Tremosa, G, Menchón, J.M, Figueras, J, Casais, L.A

“…Our aim was to validate Spanish and Catalan versions of the Liver Disease Quality of Life questionnaire (LDQOL) for use in liver transplant patients. The LDQOL…”
Get full text

Genotype lb and severity of posttransplant recurrence of hepatitis C infection—unconvictable felon or wrongly accused? by Féray, C., Cacoamo, L., Alexander, G.J.M., Ducot, B., Gugenheim, J., Casanovas, T.

“…Background & Aims: Liver transplantation for hepatitis C virus (HCV)-related liver disease is characterized by frequent graft infection by HCV The prognosis…”
Get full text

The role of mTOR inhibitors in the prevention of organ rejection in adult liver transplant patients: a focus on everolimus by Casanovas, Teresa

“…Liver transplantation remains the therapy of choice for patients with end-stage liver disease and in selected cases of hepatocellular carcinoma. While…”
Get full text

Orthotopic liver transplantation: treatment of choice in cirrhotic patients with hepatocellular carcinoma? by Moreno, P, Jaurrieta, E, Figueras, J, Benasco, C, Rafecas, A, Fabregat, J, Torras, J, Casanovas, T, Casais, L

Get more information

Predictive factors for postoperatory, early and late mortality in liver transplants by Lama, C, Ramos, E, Figueras, J, Casanovas, T, Rafecas, A, Xiol, X, Fabregat, J, Baliellas, C, Torras, J, Busquets, J, Sabaté, A, Casais, L, Jaurrieta, E

Get full text